Metacrine
San Diego
About Metacrine
Metacrine is a clinical-stage biopharmaceutical company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases. The most advanced program is focused on the farnesoid X receptor (FXR) an important drug target in multiple liver and GI diseases. Beyond the FXR program, a pipeline of novel drug candidates against other drug targets is being explored by taking advantage of internal drug discovery and development capabilities.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $173.0M
- Funding stage: IPO
- Last round: Debt Financing (Sep 2019)
- Ticker: nasdaq:MTCR
- Website: metacrine.com
- Phone: (858) 369-7800
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/metacrine-107091 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.